PAVM
PAVmed Inc

9,421
Mkt Cap
$10.17M
Volume
577,883.00
52W High
$28.44
52W Low
$6.00
PE Ratio
-0.60
PAVM Fundamentals
Price
$10.26
Prev Close
$9.57
Open
$10.26
50D MA
$9.01
Beta
1.22
Avg. Volume
2.92M
EPS (Annual)
$14.88
P/B
0.93
Rev/Employee
$76,794.87
Loading...
Loading...
News
all
press releases
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contractread more...
Benzinga·14d ago
News Placeholder
More News
News Placeholder
Why Is PAVmed Stock Skyrocketing Wednesday?
PAVmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.read more...
Benzinga·15d ago
News Placeholder
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?
The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.
Stocktwits·15d ago
News Placeholder
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard PR Newswire NEW YORK, Jan. 21...
PR Newswire·15d ago
News Placeholder
PAVmed Announces Reverse Stock Split
PAVmed Announces Reverse Stock Split PAVmed Announces Reverse Stock Split PR Newswire NEW YORK, Dec. 30, 2025 NEW YORK, Dec. 30, 2025 /PRNewswire/ --PAVmed Inc.(NASDAQ: PAVM) ('PAVmed' or the...
PR Newswire·1mo ago
News Placeholder
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...
PR Newswire·2mo ago
News Placeholder
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire NEW YORK, Nov. 20, 2025...
PR Newswire·3mo ago
News Placeholder
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and...
PR Newswire·3mo ago
News Placeholder
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 13, 2025...
PR Newswire·3mo ago
News Placeholder
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW...
PR Newswire·3mo ago
<
1
2
...
>

Latest PAVM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.